ATE174512T1 - Darstellung und verwendung von butyrylcholinesterase - Google Patents

Darstellung und verwendung von butyrylcholinesterase

Info

Publication number
ATE174512T1
ATE174512T1 AT92907864T AT92907864T ATE174512T1 AT E174512 T1 ATE174512 T1 AT E174512T1 AT 92907864 T AT92907864 T AT 92907864T AT 92907864 T AT92907864 T AT 92907864T AT E174512 T1 ATE174512 T1 AT E174512T1
Authority
AT
Austria
Prior art keywords
butyrylcholinesterase
presentation
fraction
admixture
purity
Prior art date
Application number
AT92907864T
Other languages
English (en)
Inventor
Thomas J Lynch
Original Assignee
Shire Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Lab Inc filed Critical Shire Lab Inc
Application granted granted Critical
Publication of ATE174512T1 publication Critical patent/ATE174512T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
AT92907864T 1991-02-19 1992-02-19 Darstellung und verwendung von butyrylcholinesterase ATE174512T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/657,089 US5272080A (en) 1991-02-19 1991-02-19 Production of butyrylcholinesterase

Publications (1)

Publication Number Publication Date
ATE174512T1 true ATE174512T1 (de) 1999-01-15

Family

ID=24635769

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907864T ATE174512T1 (de) 1991-02-19 1992-02-19 Darstellung und verwendung von butyrylcholinesterase

Country Status (11)

Country Link
US (1) US5272080A (de)
EP (1) EP0575479B1 (de)
JP (1) JP3134202B2 (de)
AT (1) ATE174512T1 (de)
AU (1) AU657951B2 (de)
CA (1) CA2104381C (de)
DE (1) DE69227897T2 (de)
DK (1) DK0575479T3 (de)
ES (1) ES2125892T3 (de)
GR (1) GR3029696T3 (de)
WO (1) WO1992014483A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1803730A1 (de) * 2000-04-12 2007-07-04 Human Genome Sciences, Inc. Albuminfusionsproteine
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
US20070111279A1 (en) * 2002-11-13 2007-05-17 Procell, Inc. Production of recombinant therapeutic bioscavengers against chemical and biological agents
US20060194301A1 (en) * 2004-10-09 2006-08-31 Doctor Bhupendra P Large-scale production of human serum butyrylcholinesterase as a bioscavenger
WO2006063055A2 (en) * 2004-12-06 2006-06-15 Bolder Biotechnology, Inc. Enzyme conjugates for use as detoxifying agents
CN102036687A (zh) * 2008-05-16 2011-04-27 尼克塔治疗公司 胆碱酯酶部分与聚合物的共轭物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63037A (en) * 1981-06-04 1985-12-31 Israel State Dioxaphosphorinanes,their preparation and pharmaceutical and veterinary compositions containing them
IL75553A (en) * 1985-06-18 1993-07-08 Yeda Res & Dev Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
US4963345A (en) * 1988-07-18 1990-10-16 Forrest Kim K Injectable local anesthetic antidote

Also Published As

Publication number Publication date
EP0575479A4 (en) 1994-07-13
DE69227897T2 (de) 1999-05-27
EP0575479B1 (de) 1998-12-16
JP3134202B2 (ja) 2001-02-13
EP0575479A1 (de) 1993-12-29
AU1536692A (en) 1992-09-15
WO1992014483A1 (en) 1992-09-03
JPH06508505A (ja) 1994-09-29
ES2125892T3 (es) 1999-03-16
US5272080A (en) 1993-12-21
DK0575479T3 (da) 1999-08-23
GR3029696T3 (en) 1999-06-30
DE69227897D1 (de) 1999-01-28
AU657951B2 (en) 1995-03-30
CA2104381A1 (en) 1992-08-20
CA2104381C (en) 1998-12-01

Similar Documents

Publication Publication Date Title
DE69320227D1 (de) Haarshampoo
US4773759B1 (en) Interferometer with Kerr effect compensation
GR3008027T3 (de)
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
ATE142883T1 (de) Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren
EP0355572A3 (en) Peptide derivatives, their production and use
ATE171706T1 (de) Neue therapeutische kohlenhydratmischungen zur verwendung bei prämenstruellem syndrom
DE69227897D1 (de) Darstellung und verwendung von butyrylcholinesterase
NO162420C (no) Fettsyreestere og kosmetisk preparat inneholdende disse.
GR3006419T3 (de)
GB9406107D0 (en) Improvements in or relating to the processing of mixtures
GB8902771D0 (en) Improvements in or relating to affinity chromatography
GB2281961B (en) Improvements in or relating to the movement of members
FI874431A0 (fi) Foerfarande foer rening av antikroppar.
AU579909B2 (en) Improvements in and relating to ironing tables
AU2478292A (en) Purification of factor xiii
ES8606402A1 (es) Un procedimiento para preparar una molecula de adn recom- biante
IT8547601A0 (it) Insieme di pannelli e pezzo di connessione nonche' procedimento perassemblarli
EP0565674A4 (de)
GB9400335D0 (en) Improvements in or relating to the control of linear motors
ES466162A1 (es) Perfeccionamientos introducidos en los sistemas de formacionde estructuras.
GB9325106D0 (en) Improvements in or relating to the manufacture of similar components
DE3478745D1 (en) 6h-dibenz (b,e)(1,4)oxathiepin compounds
DE59800400D1 (de) Verwendung von freifliessendem, magnetischen Eisenoxid mit 50 bis 73 Gew.-% Eisengehalt
MY102245A (en) Purification of antibodies

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee